Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
Safety and Pharmacokinetic Characteristics of HD203 in Healthy Male Volunteers (NCT01044836)Hanwha Chemical2010-01-01
Tissue Oxygenation Measurements With Modulated Light (S-FLARE) (NCT01116297)Beth Israel Deaconess Medical Center2010-01-01
Treatment of Refractory Acute Graft-Versus-Host Disease by Sequential Infusion of Allogenic Mesenchymal Stem Cell. (NCT01956903)Grupo Espanol de trasplantes hematopoyeticos y terapia celular2010-01-01
A Pharmacodynamic Study of SLM0807, HKB0701 and CJ30001 in Healthy Subject (NCT01380873)HK inno.N Corporation2010-01-01
OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas (NCT01052363)West Virginia University2010-01-01
First in Man Study With SLV342 (NCT00985478)Abbott Products2010-01-01
Effects of 500 mg Immediate Release and Extended Release Methylnaltrexone on Loperamide-induced Delay of the Oro-cecal and Whole-gut Transit Time in Healthy Subjects (NCT01596777)University Medicine Greifswald2010-01-01
To Compare the Pharmacokinetics of Avanafil in Subjects With Mild and Moderate Renal Impairment to Subjects With Normal Renal Function. (NCT01054261)VIVUS LLC2010-01-01
Effect of NN5401 in Japanese Subjects With Type 1 Diabetes (NCT01051102)Novo Nordisk A/S2010-01-01
A Bioequivalence and Food Effect Study of SEP-190 in Japanese Healthy Subjects (Study SEP 190-102) (NCT01055834)Eisai Co., Ltd.2010-01-01
Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes (LADA) (NCT01159847)European Foundation for the Study of Diabetes2010-01-01
Bioavailability Study of Sirolimus Tablets 2 mg Under Fasting Condition (NCT02296749)Dr. Reddy's Laboratories Limited2010-01-01
A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler) (NCT01056159)Teva Branded Pharmaceutical Products R&D, Inc.2010-01-01
Multiple Dose Escalation Study (14 Days) to Investigate Safety, Tolerability, PK and PD of Vardenafil and BAY60-4552 (NCT01110590)Bayer2010-01-01
Trial of Yellow Fever Inactivated Vaccine (NCT00995865)GE Healthcare2010-01-01
Improving Sleep and Daytime Functioning Among Children Diagnosed With Attention Deficit Hyperactivity Disorder (ADHD) (NCT00867451)Children's Hospital Medical Center, Cincinnati2010-01-01
Local Modulation of Immune Receptors to Enhance the Response to Dendritic Cell Vaccination in Metastatic Melanoma (NCT01216436)Duke University2010-01-01
Placebo Effect of Paracetamol in Healthy Volunteers (NCT01053650)University Hospital, Clermont-Ferrand2010-01-01
Pharmacokinetics Study: Determination of Naproxcinod and Its Metabolites After Oral Administration in Male (NCT01404598)NicOx2010-01-01
Clinical Evaluation of TrueVision System: LRI and Capsulorhexis Templates (NCT01123343)TrueVision Systems, Inc2010-01-01
Pharmacokinetics (PK) Study of Epinephrine Inhalation Aerosol in Healthy Volunteers (NCT01143051)Amphastar Pharmaceuticals, Inc.2010-01-01
Bioequivalence of a 2.5 mg Linagliptin / 850 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 850 mg Tablets in Healthy Volunteers (NCT02220647)Boehringer Ingelheim2010-01-01
Bioequivalence of a 2.5 mg Linagliptin / 500 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 500 mg Tablets Administered Together in Healthy Volunteers (NCT02221414)Boehringer Ingelheim2010-01-01
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma (NCT01034631)Hoosier Cancer Research Network2010-01-01
Safety and Feasibility of Umbilical Cord Blood Cell Transplant Into Injured Spinal Cord (NCT01046786)China Spinal Cord Injury Network2010-01-01
A Relative Bioavailability Study Between Two Formulations Of Sildenafil Citrate (NCT00904748)Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2010-01-01
Evaluation of Pharmacokinetic and Pharmacodynamic Characteristics of Indobufen, an Anticoagulant Agent (NCT01232023)Asan Medical Center2010-01-01
The Role of Mind Body Therapy in Geriatric Rehabilitation (NCT01057056)Tel-Aviv Sourasky Medical Center2010-01-01
A Study To Investigate The Clearance Of PF-04776548 From The Body Following A Very Low (Micro) Dose Of The Compound Using A Low Level Of Radiotracer To Help Quantify Expected Low Concentrations Of PF-04776548 In The Body (NCT01045317)Pfizer2010-01-01
Safety and Effectiveness of Cord Blood Stem Cell Infusion for the Treatment of Cerebral Palsy in Children (NCT01072370)Augusta University2010-01-01
Phase I/II Trial of R-CHOP + Azacytidine in Diffuse Large B Cell Lymphoma (NCT01004991)Weill Medical College of Cornell University2010-01-01
Role of the Gut Sweet Taste Receptor in the Secretion of Satiation Peptides (NCT01302574)University Hospital, Basel, Switzerland2010-01-01
Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica (NCT01364246)Shenzhen Beike Bio-Technology Co., Ltd.2010-01-01
The Effect of Hypertension Medications on Renal Blood Flow Measurements in Healthy Males (MK-0000-127) (NCT00856960)Merck Sharp & Dohme LLC2010-01-01
The Effect of Gum Chewing on Postoperative Ileus After Gynecologic Surgery (NCT01579175)Johns Hopkins University2010-01-01
To Assess the Safety of Avanafil in Healthy and Hepatically Impaired Male Subjects. (NCT01054430)VIVUS LLC2010-01-01
Drug-Drug Interaction Study With Aricept® (Donepezil) (NCT01042314)Bristol-Myers Squibb2010-01-01
A Study to Evaluate Absorption, Metabolism, and Excretion of 14C-JNJ26489112 in Healthy Male Participants (NCT01949610)Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2010-01-01
A Phase I Crossover Study of the Hemodynamic Interactions of Avanafil & Alcohol in Healthy Male Subjects. (NCT01054859)VIVUS LLC2010-01-01
Davunetide (AL-108) in Predicted Tauopathies - Pilot Study (NCT01056965)University of California, San Francisco2010-01-01
AZD5423 Multiple Ascending Dose Study (NCT01037504)AstraZeneca2010-01-01
FR01 and FR20 IUS (Intrauterine System) Wearing Study (NCT01595022)Bayer2010-01-01
Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin (NCT01046565)Galderma R&D2010-01-01
Dose Finding, Safety and Tolerability Study for AC220 to Treat Advanced Solid Tumors (NCT01049893)Daiichi Sankyo2010-01-01
Clinical Trial Based on the Use of Mesenchymal Stem Cells From Autologous Bone Marrow in Patients With Lumbar Intervertebral Degenerative Disc Disease (NCT01513694)Red de Terapia Celular2010-01-01
Mesenchymal Stem Cells to Treat Ischemic Cardiomyopathy (NCT01913886)Alexandra Cristina Senegaglia2010-01-01
ASA404 in Combination With Carboplatin/Paclitaxel/Cetuximab in Treating Patients With Refractory Solid Tumors (NCT01031212)University of California, San Francisco2010-01-01
Safety of Zileuton (Zyflo) in Combination With Imatinib Mesylate (Gleevec) in CML. (NCT01130688)University of Massachusetts, Worcester2010-01-01
Safety of Tuberculosis Vaccine, MVA85A, Administered by the Intramuscular Route and the Intradermal Route (NCT01181856)University of Oxford2010-01-01
Prophylactic Irradiation of the Para-Aortic Lymph Nodes and Supraclavicular Lymph Nodes in Locally Advanced Uterine Cervical Cancer (NCT01063387)Huazhong University of Science and Technology2010-01-01
Comparison of Depression Interventions After Acute Coronary Syndrome (NCT01032018)Columbia University2010-01-01
Nicotinic Receptors and Schizophrenia (NCT00952393)VA Office of Research and Development2010-01-01
Minocycline as Neuroprotectant After Aneurysmal Subarachnoid Hemorrhage (NCT02113176)University at Buffalo2010-01-01
TMC435-TiDP16-C121: A Study Comparing 2 Tablet Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Effect of Food on Blood Levels of TMC435 (NCT01022125)Tibotec Pharmaceuticals, Ireland2010-01-01
Bupropion Hydrochloride 300 mg Extended Release Tablets Under Fasting Conditions (NCT01046214)Teva Pharmaceuticals USA2010-01-01
Myomectomy During Cesarean Section (NCT03095014)Zagazig University2010-01-01
Computer-Based Training in Cognitive Behavior Therapy (CBT4CBT) (NCT01406899)VA Connecticut Healthcare System2010-01-01
TMS Stimulation and Cognitive Training in Alzheimer Patients (NCT01168245)Neuronix Ltd2010-01-01
The Effect of Sacral Surface Electrical Stimulation for Assisted Reproductive Technology (NCT01082913)Shiga University2010-01-01
Trial Comparing Two Techniques of Celiac Plexus Neurolysis for Treatment of Pain in Carcinoma Pancreas (NCT01182831)Asian Institute of Gastroenterology, India2010-01-01
Dl-3-n-butylphthalide and Cerebrolysin Treatment in Acute Ischemic Stroke (NCT02149875)Shanghai 6th People's Hospital2010-01-01
Safety, Tolerability and Pharmacokinetics Study Assessing Ascending Single Oral JTK-853 Doses in Healthy Subjects (NCT01475981)Akros Pharma Inc.2010-01-01
Drug-drug Interaction Study of Dapagliflozin With Voglibose in Japanese Type 2 Diabetes Mellitus Patients (NCT01055652)AstraZeneca2010-01-01
Trial on Safety and Pharmacokinetics of Intravaginal Curcumin (NCT01035580)Emory University2010-01-01
A Phase I, Open-label Trial to Explore the Pharmacokinetics, Safety and Tolerability of TMC278 (Rilpivirine) 25 mg Once Daily Following a 2-week Period Receiving Efavirenz, in Healthy Male and Female Volunteers (NCT01268839)Tibotec, Inc2010-01-01
TMC435-TiDP16-C113: A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of TMC435 (NCT01046058)Tibotec Pharmaceuticals, Ireland2010-01-01
Tolerability Comparison of Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin (NCT01046396)Galderma R&D2010-01-01
Dose-Escalation Phase 1 Study of G-202 (Mipsagargin) in Patients With Advanced Solid Tumors (NCT01056029)GenSpera, Inc.2010-01-01
Pharmacokinetics/Dynamics of Basal (Continuous) Insulin Infusion Administered Either Intradermally or Subcutaneously (NCT01061216)Becton, Dickinson and Company2010-01-01
To Evaluate if Multiple Doses of Ketoconazole Change the Blood Concentration of YM150 (Darexaban) (NCT01405989)Astellas Pharma Inc2010-01-01
Effects of Traumeel®S Tablets on Recovery and Inflammatory Immune Response After Repeated Bouts of Exercise (NCT01921777)Prof. Dr. med. Frank Christoph Mooren2010-01-01
To Evaluate Whether Naproxen and Darexaban (YM150) Interact in Their Effects (NCT01409603)Astellas Pharma Inc2010-01-01
Stem Cell Therapy in Traumatic Brain Injury (NCT02028104)Neurogen Brain and Spine Institute2010-01-01
A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma (NCT01060904)Seagen Inc.2010-01-01
Double Blind Randomized Placebo Controlled Trial of FOSTRAP Chewing Gum in Patients With CKD and Hyperphosphatemia (NCT01057108)Denver Nephrologists, P.C.2010-01-01
Contrastim Stroke Trial (NCT01049802)Shirley Ryan AbilityLab2010-01-01
A Study to Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of JNJ-404118413 in Healthy Male Patients (NCT01951053)Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2010-01-01
Single Dose Study With 4SC-203 in Healthy Volunteers (NCT01054937)4SC AG2010-01-01
Bioengineered Allogeneic Immune Cells (AlloStim) Not Requiring HLA Donor Match for Blood Cancers (NCT00861965)Mirror Biologics, Inc.2010-01-01
A PET Study in Healthy Volunteers (NCT01424449)GlaxoSmithKline2010-01-01
A Bioequivalence Study Of AG-013736 Tablets Under Fed Conditions In Healthy Volunteers (NCT01020136)Pfizer2010-01-01
Anti-CD3 & Anti-CD7 Ricin A Immunotoxin-Combination for Acute Graft Versus Host Disease (NCT00640497)Henogen2010-01-01
Proton Beam Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery (NCT01076231)Abramson Cancer Center at Penn Medicine2010-01-01
Phase 1 Study to Evaluate RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy Adults (NCT01046539)National Institute on Drug Abuse (NIDA)2010-01-01
Open Label, Dose Escalation Trial of Oral Eg5 Kinesin-spindle Inhibitor 4SC-205 in Patients With Advanced Malignancies (NCT01065025)4SC AG2010-01-01
Relative Bioavailability of BI 671800 HEA in Healthy Male Volunteers (NCT02222233)Boehringer Ingelheim2010-01-01
Evaluation of Pandemic Influenza A (H1N1)Candidate Vaccines (NCT01111968)Butantan Institute2010-01-01
Safety, Tolerability, and Activity Study of ISIS SOD1Rx to Treat Familial Amyotrophic Lateral Sclerosis (ALS) Caused by SOD1 Gene Mutations (NCT01041222)Ionis Pharmaceuticals, Inc.2010-01-01
Erlotinib Is Being Studied With Or Without An Investigational Drug, PF-02341066, In Patients With Lung Cancer (NCT00965731)Pfizer2010-01-01
Examining the Role of Genetics in Determining the Immune Response to an HIV Vaccine in HIV-Uninfected Adult Twins (NCT01054872)National Institute of Allergy and Infectious Diseases (NIAID)2010-01-01
The Effect Of Lersivirine (UK-453,061) On Qt Intervals In Healthy Subjects (NCT00936871)Pfizer2010-01-01
Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion (NCT01028248)California Retina Consultants2010-01-01
Periodontal Ligament Stem Cell Implantation in the Treatment of Periodontitis (NCT01082822)Air Force Military Medical University, China2010-01-01
Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Hereditary Ataxia (NCT01360164)Shenzhen Beike Bio-Technology Co., Ltd.2010-01-01
A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone With Dextromethorphan and Theophylline in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT01017939)Janssen Research & Development, LLC2010-01-01
Pilot Study Evaluating the Efficacy of AlloMEM After Loop Ileostomy (NCT01113736)University Hospitals Cleveland Medical Center2010-01-01
Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis (NCT01056471)Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud2010-01-01
Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU) (NCT01081574)Faes Farma, S.A.2010-01-01
Biological Treatment of Amyotrophic Lateral Sclerosis (NCT02193893)Pomeranian Medical University Szczecin2010-01-01
Endoscopic Ethanol Ablation of Communicating Pancreatic Cystic Neoplasms (NCT01057355)Mayo Clinic2010-01-01
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.